Table 1.
Variables | Total (N = 32) |
HU < 20 (N = 18) |
HU ≥ 20 (N = 14) |
P |
---|---|---|---|---|
Age, year | 73 [59-78] | 69 [53-76] | 77 [70-79] | .03 |
Male | 19 (59) | 9 (50) | 10 (71) | .29 |
Body mass index, kg/m2 | 20.4 [18.5-22.4] | 20.2 [18.5-22.9] | 21.0 [17.7-22.6] | .75 |
ECOG-PS | .03 | |||
0 | 19 (59) | 14 (78) | 5 (36) | |
1 | 13 (41) | 4 (22) | 9 (64) | |
Charlson Comorbidity Index | 0 [0-2] | 0 [0-0] | 1.5 [0-2] | .03 |
Maximum transverse diameter of tumor, mm | 124 [85-180] | 144 [85-197] | 105 [82-146] | .20 |
Pathological type | ||||
Dedifferentiated | 16 (50) | 7 (39) | 9 (64) | .15 |
Well-differentiated | 11 (34) | 10 (56) | 1 (7) | .005 |
Myxoid | 3 (9) | 0 | 3 (21) | .07 |
Pleomorphic | 2 (6) | 1 (6) | 1 (7) | 1.00 |
Primary site | ||||
Retroperitoneal | 25 (78) | 14 (78) | 11 (79) | 1.00 |
Mediastinal | 1 (3) | 0 (0) | 1 (7) | .44 |
Mesentery | 3 (9) | 1 (6) | 2 (14) | .57 |
Femoral region | 3 (9) | 3 (16) | 0 (0) | .24 |
Recurrence | 15 (47) | 5 (28) | 10 (71) | |
Overall death | 6 (19) | 1 (6) | 5 (36) |
Values in numbers (%) or median [interquartile range].
ECOG-PS, Eastern Cooperative Oncology Group performance status.